Haack M, Hinze-Selch D, Fenzel T, Kraus T, Kühn M, Schuld A, Pollmächer T
Max Planck Institute of Psychiatry, Munich, Germany.
J Psychiatr Res. 1999 Sep-Oct;33(5):407-18. doi: 10.1016/s0022-3956(99)00021-7.
It has been hypothesized that the immune system plays a pathogenetic role in psychiatric disorders, in particular in major depression and schizophrenia. This hypothesis is supported by a number of reports on altered circulating levels and in vitro production of cytokines in these disorders. However, the respective evidence is not consistent. This may be in part due to an incomplete control for numerous confounding influences in earlier studies. We investigated the plasma levels of cytokines and soluble cytokine receptors in psychiatric patients (N = 361) upon hospital admission and compared the results to those obtained in healthy controls (N = 64). By multiple regression analysis we found that circulating levels of interleukin-1 receptor antagonist (IL-1Ra), soluble IL-2 receptor (sIL-2R), tumor necrosis factor-alpha (TNF-alpha), soluble TNF receptors (sTNF-R p55, sTNF-R p75) and IL-6 were significantly affected by age, the body mass index (BMI), gender, smoking habits, ongoing or recent infectious diseases, or prior medication. Cytokine or cytokine receptor levels were significantly increased in patients treated with clozapine (sIL-2R, sTNF-R p75), lithium (TNF-alpha, sTNF-R p75, IL-6) or benzodiazepines (TNF-alpha, sTNF-R p75). Taking all these confounding factors into account, we found no evidence for disease-related alterations in the levels of IL-1Ra, sIL-2R, sTNF-R p75 and IL-6, whereas levels of TNF-alpha and sTNF-R p55 in major depression and sTNF-R p55 in schizophrenia were slightly decreased compared to healthy controls. We conclude that, if confounding factors are carefully taken into account, plasma levels of the above mentioned cytokines and cytokine receptors yield little, if any, evidence for immunopathology in schizophrenia or major depression.
有假说认为,免疫系统在精神疾病,尤其是重度抑郁症和精神分裂症中发挥致病作用。这一假说得到了一些报告的支持,这些报告指出这些疾病中细胞因子的循环水平和体外产生发生了改变。然而,各自的证据并不一致。这可能部分是由于早期研究中对众多混杂影响因素控制不完全。我们调查了361名精神科患者入院时血浆细胞因子和可溶性细胞因子受体水平,并将结果与64名健康对照者的结果进行比较。通过多元回归分析,我们发现白细胞介素-1受体拮抗剂(IL-1Ra)、可溶性IL-2受体(sIL-2R)、肿瘤坏死因子-α(TNF-α)、可溶性TNF受体(sTNF-R p55、sTNF-R p75)和IL-6的循环水平受年龄、体重指数(BMI)、性别、吸烟习惯、正在发生或近期的传染病或先前用药的显著影响。接受氯氮平(sIL-2R、sTNF-R p75)、锂盐(TNF-α、sTNF-R p75、IL-6)或苯二氮䓬类药物(TNF-α、sTNF-R p75)治疗的患者,其细胞因子或细胞因子受体水平显著升高。考虑到所有这些混杂因素,我们没有发现IL-1Ra、sIL-2R、sTNF-R p75和IL-6水平存在与疾病相关改变的证据,而与健康对照相比,重度抑郁症患者的TNF-α和sTNF-R p55水平以及精神分裂症患者的sTNF-R p55水平略有下降。我们得出结论,如果仔细考虑混杂因素,上述细胞因子和细胞因子受体的血浆水平几乎没有(如果有的话)证据支持精神分裂症或重度抑郁症存在免疫病理学。